AAAAAA
Results: 1-25/265
Authors:
Kirby, R
Moul, J
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 4(3), 2001, pp. 137-137
Authors:
Benoit, RM
Gronberg, H
Naslund, MJ
Citation: Rm. Benoit et al., A quantitative analysis of the costs and benefits of prostate cancer screening, PROSTATE C, 4(3), 2001, pp. 138-145
Authors:
Lujan, M
Paez, A
Llanes, L
Miravalles, E
Berenguer, A
Citation: M. Lujan et al., Prostate specific antigen density. Is there a role for this parameter whenscreening for prostate cancer?, PROSTATE C, 4(3), 2001, pp. 146-149
Authors:
Tozawa, K
Akita, H
Kawai, N
Okamura, T
Sasaki, S
Hayashi, Y
Kohri, K
Citation: K. Tozawa et al., KAI1 expression can be a predictor of stage A prostate cancer progression, PROSTATE C, 4(3), 2001, pp. 150-153
Authors:
Soulie, M
Grosclaude, P
Villers, A
Menegoz, F
Schaffer, P
Mace-Lesec'h, J
Molinier, L
Sauvage-Machelard, M
Citation: M. Soulie et al., A population-based study on management of prostate cancer in four regions of France, PROSTATE C, 4(3), 2001, pp. 154-160
Authors:
Peters, JL
Fairney, A
Kyd, P
Patel, A
Rogers, S
Webster, JJ
Vale, JA
Witherow, RON
Citation: Jl. Peters et al., Bone loss associated with the use of LHRH agonists in prostate cancer, PROSTATE C, 4(3), 2001, pp. 161-166
Authors:
Sriprasad, S
Dew, TK
Muir, GH
Thompson, PM
Mulvin, D
Choi, WH
Dickinson, IK
Sherwood, RA
Citation: S. Sriprasad et al., Validity of PSA, free/total PSA ratio and complexed/total PSA ratio measurements in men with acute urinary retention, PROSTATE C, 4(3), 2001, pp. 167-172
Authors:
Eri, LM
Tveter, KJ
Citation: Lm. Eri et Kj. Tveter, Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA),acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH), PROSTATE C, 4(3), 2001, pp. 173-177
Authors:
Bowden, EA
Foley, SJ
Citation: Ea. Bowden et Sj. Foley, Haematuria; a late complication of TURP?, PROSTATE C, 4(3), 2001, pp. 178-179
Citation: British Prostate Group - Spring Meeting - 2(nd) and 3(rd) April 2001 - TheWestern Conference Centre - Sackville Street, Manchseter - Abstracts, PROSTATE C, 4(3), 2001, pp. 180-190
Authors:
Kirby, R
Moul, J
Brawer, M
Citation: R. Kirby et al., Untitled, PROSTATE C, 4(2), 2001, pp. 71-71
Authors:
Chodak, GW
Kolvenbag, GJCM
Citation: Gw. Chodak et Gjcm. Kolvenbag, Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?, PROSTATE C, 4(2), 2001, pp. 72-80
Authors:
Liu, YQ
Kyle, E
Patel, S
Housseau, F
Hakim, F
Lieberman, R
Pins, M
Blagosklonny, MV
Bergan, RC
Citation: Yq. Liu et al., Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells, PROSTATE C, 4(2), 2001, pp. 81-91
Authors:
Slater, MD
Delprado, WJ
Murphy, CR
Barden, JA
Citation: Md. Slater et al., Detection of preneoplasia in histologically normal prostate biopsies, PROSTATE C, 4(2), 2001, pp. 92-96
An investigation into the spatial relationship between prostate intraepithelial neoplasia and cancer
Authors:
Green, JSA
Knight, RJ
Hunter-Campbell, P
St George, DP
Walker, T
Wilson, C
Jarmulowicz, M
Kaisary, AV
Citation: Jsa. Green et al., An investigation into the spatial relationship between prostate intraepithelial neoplasia and cancer, PROSTATE C, 4(2), 2001, pp. 97-100
Authors:
Mydlo, JH
Tieng, NL
Volpe, MA
Chaiken, R
Kral, JG
Citation: Jh. Mydlo et al., A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate, PROSTATE C, 4(2), 2001, pp. 101-105
Authors:
Dall'Era, MA
Shih, SJ
Yang, J
Benik, S
Gandour-Edwards, R
Evans, CP
Citation: Ma. Dall'Era et al., Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer, PROSTATE C, 4(2), 2001, pp. 106-111
Authors:
Schasfoort, EMC
van de Beek, C
Newling, DWW
Citation: Emc. Schasfoort et al., Safety and efficacy of a nonsteroidal anti-androgen, based on results of apost marketing surveillance of nilutamide, PROSTATE C, 4(2), 2001, pp. 112-117
Authors:
Soulie, M
Villers, A
Grosclaude, P
Menegoz, F
Schaffer, P
Mace-Lesec'h, J
Sauvage-Machelard, M
Grand, A
Citation: M. Soulie et al., A population-based study on radical prostatectomy in France, PROSTATE C, 4(2), 2001, pp. 118-123
Authors:
Vallancien, G
Pariente, P
Citation: G. Vallancien et P. Pariente, Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France, PROSTATE C, 4(2), 2001, pp. 124-131
Authors:
Belldegrun, A
Citation: A. Belldegrun, What's hot in the prostate?, PROSTATE C, 4(1), 2001, pp. 1-2
Citation: Gene/environment interaction studies in prostate cancer, PROSTATE C, 4(1), 2001, pp. 2-3
Citation: New funding initiatives in prostate cancer, PROSTATE C, 4(1), 2001, pp. 2-2
Citation: PSA prostate cancer screening trial, PROSTATE C, 4(1), 2001, pp. 3-4
Citation: Percentage of carcinoma at radical prostatectomy is an independent predictor of recurrence, PROSTATE C, 4(1), 2001, pp. 4-4